{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:08:47Z","timestamp":1778580527260,"version":"3.51.4"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s42000-018-0072-y","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T21:56:13Z","timestamp":1542664573000},"page":"479-490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An update on adrenal endocrinology: significant discoveries in the last 10\u00a0years and where the field is heading in the next decade"],"prefix":"10.1007","volume":"17","author":[{"given":"Crystal D. C.","family":"Kamilaris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"72_CR1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrm3432","volume":"12","author":"SS Taylor","year":"2012","unstructured":"Taylor SS, Ilouz R, Zhang P et al (2012) Assembly of allosteric macromolecular switches: lessons from PKA. Nat Rev Mol Cell Biol 12:646\u2013658","journal-title":"Nat Rev Mol Cell Biol"},{"key":"72_CR2","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein LS, Shenker A, Gejman PV et al (1991) Activating mutations of the stimulatory G protein in the McCune\u2013Albright syndrome. N Engl J Med 325:1688\u20131695","journal-title":"N Engl J Med"},{"key":"72_CR3","unstructured":"Boyce AM, Collins MT (2015) Fibrous dysplasia\/McCune-Albright syndrome. In: Adam MP, Ardinger HH, Pagon RA et al (eds) GeneReviews\u00ae [internet]. University of Washington, Seattle, Seattle (WA), 1993-2018"},{"key":"72_CR4","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2009-2321","volume":"95","author":"RJ Brown","year":"2010","unstructured":"Brown RJ, Kelly MH, Collins MT (2010) Cushing syndrome in McCune-Albright syndrome. J Cin Endocrinol Metab 95:1508\u20131515","journal-title":"J Cin Endocrinol Metab"},{"issue":"9","key":"72_CR5","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/PAS.0b013e31821ec4ce","volume":"35","author":"JA Carney","year":"2011","unstructured":"Carney JA, Young WF, Stratakis CA (2011) Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome. Am J Surg Pathol 35(9):1311\u20131326","journal-title":"Am J Surg Pathol"},{"key":"72_CR6","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/344579","volume":"71","author":"L Groussin","year":"2002","unstructured":"Groussin L, Kirschner LS, Vincent-Dejean C et al (2002) Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet 71:1433\u20131442","journal-title":"Am J Hum Genet"},{"issue":"4","key":"72_CR7","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1530\/EJE-15-0209","volume":"173","author":"R Correa","year":"2015","unstructured":"Correa R, Salpea P, Stratakis C (2015) Carney complex: an update. Eur J Endocrinol 173(4):M85\u2013M97","journal-title":"Eur J Endocrinol"},{"key":"72_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","volume":"26","author":"LS Kirschner","year":"2000","unstructured":"Kirschner LS et al (2000) Mutations of the gene encoding the protein kinase A type I-\u03b1 regulatory subunit in patients with the Carney complex. Nat Genet 26:89\u201392","journal-title":"Nat Genet"},{"key":"72_CR9","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","volume":"94","author":"J Bertherat","year":"2009","unstructured":"Bertherat J, Horvath A, Groussin L et al (2009) Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2032-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab 94:2085\u20132091","journal-title":"J Clin Endocrinol Metab"},{"key":"72_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11102-006-0266-1","volume":"9","author":"L Cazabat","year":"2006","unstructured":"Cazabat L, Ragazzon B, Groussin L et al (2006) PRKAR1A mutations in primary pigmented nodular adrenocortical disease. Pituitary 9:211\u2013219","journal-title":"Pituitary"},{"issue":"17","key":"72_CR11","first-page":"5308","volume":"63","author":"J Bertherat","year":"2003","unstructured":"Bertherat J, Groussin L, Sandrini F et al (2003) Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res 63(17):5308\u20135319","journal-title":"Cancer Res"},{"issue":"6","key":"72_CR12","doi-asserted-by":"crossref","first-page":"e1000980","DOI":"10.1371\/journal.pgen.1000980","volume":"6","author":"I Sahut-Barnola","year":"2010","unstructured":"Sahut-Barnola I, de Joussineau C, Val P et al (2010) Cushing\u2019s syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice. PLoS Genet 6(6):e1000980","journal-title":"PLoS Genet"},{"issue":"7","key":"72_CR13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng1809","volume":"38","author":"A Horvath","year":"2006","unstructured":"Horvath A, Boikos S, Giatzakis C et al (2006) A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 38(7):794\u2013800","journal-title":"Nat Genet"},{"issue":"24","key":"72_CR14","doi-asserted-by":"crossref","first-page":"11571","DOI":"10.1158\/0008-5472.CAN-06-2914","volume":"66","author":"A Horvath","year":"2006","unstructured":"Horvath A, Giatzakis C, Robinson-White A et al (2006) Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res 66(24):11571\u201311575","journal-title":"Cancer Res"},{"issue":"12","key":"72_CR15","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","volume":"14","author":"R Lib\u00e9","year":"2008","unstructured":"Lib\u00e9 R, Fratticci A, Coste J et al (2008) Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clin Cancer Res 14(12):4016\u20134024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"72_CR16","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.1210\/jc.2010-1704","volume":"96","author":"R Lib\u00e9","year":"2011","unstructured":"Lib\u00e9 R, Horvath A, Vezzosi D et al (2011) Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype. J Clin Endocrinol Metab 96(1):E208\u2013E214","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"72_CR17","doi-asserted-by":"crossref","first-page":"E135","DOI":"10.1210\/jc.2010-1655","volume":"96","author":"FR Faucz","year":"2011","unstructured":"Faucz FR, Horvath A, Rothenbuhler A et al (2011) Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer. J Clin Endocrinol Metab 96(1):E135\u2013E140","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"72_CR18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJMc0706182","volume":"358","author":"A Horvath","year":"2008","unstructured":"Horvath A, Mericq V, Stratakis CA (2008) Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N Engl J Med 358(7):750\u2013752","journal-title":"N Engl J Med"},{"issue":"2","key":"72_CR19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2265.2012.04366.x","volume":"77","author":"A Rothenbuhler","year":"2012","unstructured":"Rothenbuhler A, Horvath A, Lib\u00e9 R et al (2012) Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours. Clin Endocrinol 77(2):195\u2013199","journal-title":"Clin Endocrinol"},{"issue":"1","key":"72_CR20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/EJE-09-0027","volume":"161","author":"EI Bimpaki","year":"2009","unstructured":"Bimpaki EI, Nesterova M, Stratakis CA (2009) Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes. Eur J Endocrinol 161(1):153\u2013161","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"72_CR21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","volume":"370","author":"F Beuschlein","year":"2014","unstructured":"Beuschlein F, Fassnacht M, Assi\u00e9 G et al (2014) Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome. N Engl J Med 370(11):1019\u20131028","journal-title":"N Engl J Med"},{"issue":"6186","key":"72_CR22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1126\/science.1249480","volume":"344","author":"Y Cao","year":"2014","unstructured":"Cao Y, He M, Gao Z et al (2014) Activating hotspot L205R mutation in PRKACA and adrenal Cushing\u2019s syndrome. Science 344(6186):913\u2013917","journal-title":"Science"},{"issue":"6186","key":"72_CR23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1126\/science.1252328","volume":"344","author":"Y Sato","year":"2014","unstructured":"Sato Y, Maekawa S, Ishii R et al (2014) Recurrent somatic mutations underlie corticotropin-independent Cushing\u2019s syndrome. Science 344(6186):917\u2013920","journal-title":"Science"},{"issue":"6","key":"72_CR24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng.2956","volume":"46","author":"G Goh","year":"2014","unstructured":"Goh G, Scholl UI, Healy JM et al (2014) Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat Genet 46(6):613\u2013617","journal-title":"Nat Genet"},{"issue":"10","key":"72_CR25","doi-asserted-by":"crossref","first-page":"E2093","DOI":"10.1210\/jc.2014-2152","volume":"99","author":"G Dalmazi Di","year":"2014","unstructured":"Di Dalmazi G, Kisker C, Calebiro D et al (2014) Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing\u2019s syndrome: a European multicentric study. J Clin Endocrinol Metab 99(10):E2093\u2013E2100","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"72_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrendo.2016.24","volume":"12","author":"M Lodish","year":"2016","unstructured":"Lodish M, Stratakis CA (2016) A genetic and molecular update on adrenocortical causes of Cushing syndrome. Nat Rev Endocrinol 12(5):255\u2013262","journal-title":"Nat Rev Endocrinol"},{"key":"72_CR27","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","volume":"16","author":"S Gaujoux","year":"2010","unstructured":"Gaujoux S, Pinson S, Gimenez-Roqueplo AP et al (2010) Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. Clin Cancer Res 16:5133\u20135141","journal-title":"Clin Cancer Res"},{"key":"72_CR28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","volume":"166","author":"B Gatta-Cherifi","year":"2012","unstructured":"Gatta-Cherifi B, Chabre O, Murat A et al (2012) Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d\u2019etude des Tumeurs endocrines database. Eur J Endocrinol 166:269\u2013279","journal-title":"Eur J Endocrinol"},{"key":"72_CR29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","volume":"189","author":"B Shuch","year":"2013","unstructured":"Shuch B, Ricketts CJ, Vocke CD et al (2013) Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol 189:430\u2013435","journal-title":"J Urol"},{"issue":"22","key":"72_CR30","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","volume":"369","author":"G Assi\u00e9","year":"2013","unstructured":"Assi\u00e9 G, Lib\u00e9 R, Espiard S et al (2013) ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome. N Engl J Med 369(22):2105\u20132114","journal-title":"N Engl J Med"},{"issue":"10","key":"72_CR31","first-page":"3531","volume":"85","author":"H Mircescu","year":"2000","unstructured":"Mircescu H, Jilwan J, N'Diaye N et al (2000) Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing\u2019s syndrome? J Clin Endocrinol Metab 85(10):3531\u20133536","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"72_CR32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJM199911183412104","volume":"341","author":"A Lacroix","year":"1999","unstructured":"Lacroix A, Hamet P, Boutin JM (1999) Leuprolide acetate therapy in luteinizing hormone--dependent Cushing\u2019s syndrome. N Engl J Med 341(21):1577\u20131581","journal-title":"N Engl J Med"},{"issue":"8","key":"72_CR33","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2009-0516","volume":"94","author":"HP Hsiao","year":"2009","unstructured":"Hsiao HP, Kirschner LS, Bourdeau I et al (2009) Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J Clin Endocrinol Metab 94(8):2930\u20132937","journal-title":"J Clin Endocrinol Metab"},{"key":"72_CR34","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/jc.2005-2608","volume":"91","author":"I Bourdeau","year":"2006","unstructured":"Bourdeau I, Matyakhina L, Stergiopoulos SG et al (2006) 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab 91:3626\u20133632","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"72_CR35","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/sj.onc.1207277","volume":"23","author":"I Bourdeau","year":"2004","unstructured":"Bourdeau I, Antonini SR, Lacroix A et al (2004) Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene 23(8):1575\u20131585","journal-title":"Oncogene"},{"issue":"4","key":"72_CR36","doi-asserted-by":"crossref","first-page":"E728","DOI":"10.1210\/jc.2010-2420","volume":"96","author":"MQ Almeida","year":"2011","unstructured":"Almeida MQ, Harran M, Bimpaki EI et al (2011) Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions. J Clin Endocrinol Metab 96(4):E728\u2013E738","journal-title":"J Clin Endocrinol Metab"},{"key":"72_CR37","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","volume":"65","author":"F Tissier","year":"2005","unstructured":"Tissier F, Cavard C, Groussin L et al (2005) Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res 65:7622\u20137627","journal-title":"Cancer Res"},{"issue":"6","key":"72_CR38","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/jc.2014-4204","volume":"100","author":"S Espiard","year":"2015","unstructured":"Espiard S, Drougat L, Lib\u00e9 R et al (2015) ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences. J Clin Endocrinol Metab 100(6):E926\u2013E935","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"72_CR39","doi-asserted-by":"crossref","first-page":"E900","DOI":"10.1210\/jc.2014-4167","volume":"100","author":"M Zilbermint","year":"2015","unstructured":"Zilbermint M, Xekouki P, Faucz FR et al (2015) Primary aldosteronism and ARMC5Variants. J Clin Endocrinol Metab 100(6):E900\u2013E909","journal-title":"J Clin Endocrinol Metab"},{"key":"72_CR40","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","volume":"369","author":"E Louiset","year":"2013","unstructured":"Louiset E, Duparc C, Young J et al (2013) Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N Engl J Med 369:2115\u20132125","journal-title":"N Engl J Med"},{"key":"72_CR41","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199210013271402","volume":"327","author":"A Lacroix","year":"1992","unstructured":"Lacroix A, Bolt\u00e9 E, Tremblay J et al (1992) Gastric inhibitory polypeptide-dependent cortisol hypersecretion: a new cause of Cushing\u2019s syndrome. N Engl J Med 327:974\u2013980","journal-title":"N Engl J Med"},{"issue":"18","key":"72_CR42","doi-asserted-by":"crossref","first-page":"e92184","DOI":"10.1172\/jci.insight.92184","volume":"2","author":"AL Lecoq","year":"2017","unstructured":"Lecoq AL, Stratakis CA, Viengchareun S et al (2017) Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing\u2019s syndrome. JCI Insight 2(18):e92184","journal-title":"JCI Insight"},{"key":"72_CR43","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C et al (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293\u20132300","journal-title":"J Am Coll Cardiol"},{"key":"72_CR44","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","volume":"66","author":"WF Young","year":"2007","unstructured":"Young WF (2007) Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol 66:607\u2013618","journal-title":"Clin Endocrinol"},{"issue":"22","key":"72_CR45","first-page":"1109","volume":"95","author":"DJ Sutherland","year":"1966","unstructured":"Sutherland DJ, Ruse JL, Laidlaw JC (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 95(22):1109","journal-title":"Can Med Assoc J"},{"issue":"6357","key":"72_CR46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M et al (1992) A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355(6357):262","journal-title":"Nature"},{"issue":"8","key":"72_CR47","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/HJH.0b013e3283028352","volume":"26","author":"N Sukor","year":"2008","unstructured":"Sukor N, Mulatero P, Gordon RD et al (2008) Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. Hypertension 26(8):1577\u20131582","journal-title":"Hypertension"},{"issue":"9","key":"72_CR48","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/jhh.2010.93","volume":"25","author":"KJ Carss","year":"2011","unstructured":"Carss KJ, Stowasser M, Gordon RD et al (2011) Further study of chromosome 7p22 to identify the molecular basis of familial hyperaldosteronism type II. J Hum Hypertens 25(9):560\u2013564","journal-title":"J Hum Hypertens"},{"key":"72_CR49","doi-asserted-by":"crossref","first-page":"e06315","DOI":"10.7554\/eLife.06315","volume":"4","author":"UI Scholl","year":"2015","unstructured":"Scholl UI, St\u00f6lting G, Nelson-Williams C et al (2015) Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. elife 4:e06315","journal-title":"elife"},{"issue":"8","key":"72_CR50","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","volume":"93","author":"DS Geller","year":"2008","unstructured":"Geller DS, Zhang J, Wisgerhof MV et al (2008) A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 93(8):3117\u20133123","journal-title":"J Clin Endocrinol Metab"},{"issue":"6018","key":"72_CR51","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"Choi M, Scholl UI, Yue P et al (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331(6018):768\u2013772","journal-title":"Science"},{"issue":"6","key":"72_CR52","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/cen.13132","volume":"85","author":"A Sertedaki","year":"2016","unstructured":"Sertedaki A, Markou A, Vlachakis D et al (2016) Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion. Clin Endocrinol 85(6):845\u2013851","journal-title":"Clin Endocrinol"},{"key":"72_CR53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","volume":"45","author":"F Beuschlein","year":"2013","unstructured":"Beuschlein F, Boulkroun S, Osswald A et al (2013) Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 45:440\u2013444","journal-title":"Nat Genet"},{"key":"72_CR54","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","volume":"45","author":"UI Scholl","year":"2013","unstructured":"Scholl UI, Goh G, Stolting G et al (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 45:1050\u20131054","journal-title":"Nat Genet"},{"key":"72_CR55","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","volume":"45","author":"EAB Azizan","year":"2013","unstructured":"Azizan EAB, Poulsen H, Tuluc P et al (2013) Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet 45:1055\u20131060","journal-title":"Nat Genet"},{"key":"72_CR56","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","volume":"64","author":"FL Fernandes-Rosa","year":"2014","unstructured":"Fernandes-Rosa FL, Williams TA, Riester A et al (2014) Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64:354\u2013361","journal-title":"Hypertension"},{"issue":"3","key":"72_CR57","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2015-3239","volume":"101","author":"K Nanba","year":"2016","unstructured":"Nanba K, Chen AX, Omata K et al (2016) Molecular heterogeneity in aldosterone-producing adenomas. J Clin Endocrinol Metab 101(3):999\u20131007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"72_CR58","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2011-2244","volume":"97","author":"J Anselmo","year":"2012","unstructured":"Anselmo J, Medeiros S, Carneiro V et al (2012) A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer. J Clin Endocrinol Metab 97(2):351\u2013359","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"72_CR59","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"Else T, Kim AC, Sabolch A et al (2014) Adrenocortical carcinoma. Endocr Rev 35(2):282\u2013226","journal-title":"Endocr Rev"},{"issue":"3","key":"72_CR60","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jc.2002-021117","volume":"88","author":"MH Bernard","year":"2003","unstructured":"Bernard MH, Sidhu S, Berger N et al (2003) A case report in favor of a multistep adrenocortical tumorigenesis. J Clin Endocrinol Metab 88(3):998\u20131001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"72_CR61","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","volume":"46","author":"G Assi\u00e9","year":"2014","unstructured":"Assi\u00e9 G, Letouz\u00e9 E, Fassnacht M et al (2014) Integrated genomic characterization of adrenocortical carcinoma. Nat Genet 46(6):607\u2013612","journal-title":"Nat Genet"},{"key":"72_CR62","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","volume":"29","author":"S Zeng","year":"2016","unstructured":"Zeng S, Cherniack AD, Dewal N et al (2016) Comprehensive pan-genomic characterization of adrenocortical carcinoma. Cancer Cell 29:723\u2013736","journal-title":"Cancer Cell"},{"issue":"23","key":"72_CR63","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","volume":"366","author":"M Fassnacht","year":"2012","unstructured":"Fassnacht M, Terzolo M, Allolio B et al (2012) Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med 366(23):2189\u20132197","journal-title":"N Engl J Med"},{"issue":"5944","key":"72_CR64","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","volume":"325","author":"HX Hao","year":"2009","unstructured":"Hao HX, Khalimonchuk O, Schraders M et al (2009) SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325(5944):1139\u20131142","journal-title":"Science"},{"issue":"3","key":"72_CR65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng.533","volume":"42","author":"Y Qin","year":"2010","unstructured":"Qin Y, Yao L, King EE et al (2010) Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 42(3):229\u2013233","journal-title":"Nat Genet"},{"issue":"4","key":"72_CR66","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(10)70007-3","volume":"11","author":"JP Bayley","year":"2010","unstructured":"Bayley JP, Kunst HP, Cascon A et al (2010) SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol 11(4):366\u2013372","journal-title":"Lancet Oncol"},{"issue":"15","key":"72_CR67","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","volume":"19","author":"N Burnichon","year":"2010","unstructured":"Burnichon N, Bri\u00e8re JJ, Lib\u00e9 R et al (2010) SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19(15):3011\u20133020","journal-title":"Hum Mol Genet"},{"key":"72_CR68","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","volume":"43","author":"I Comino-Mendez","year":"2011","unstructured":"Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F et al (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43:663","journal-title":"Nat Genet"},{"key":"72_CR69","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","volume":"57","author":"G Eisenhofer","year":"2011","unstructured":"Eisenhofer G, Lenders JW, Timmers H et al (2011) Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem 57:411","journal-title":"Clin Chem"},{"issue":"6","key":"72_CR70","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, Duh QY, Eisenhofer G et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(6):1915\u20131942","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"72_CR71","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.bbabio.2011.07.003","volume":"1807","author":"C Bardella","year":"2011","unstructured":"Bardella C, Pollard PJ, Tomlinson I (2011) SDH mutations in cancer. Biochim Biophys Acta 1807(11):1432\u20131443","journal-title":"Biochim Biophys Acta"},{"issue":"31","key":"72_CR72","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1200\/JCO.2011.34.6353","volume":"29","author":"KS King","year":"2011","unstructured":"King KS, Prodanov T, Kantorovich V et al (2011) Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol 29(31):4137\u20134142","journal-title":"J Clin Oncol"},{"key":"72_CR73","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1677\/ERC-08-0214","volume":"16","author":"HK Ghayee","year":"2009","unstructured":"Ghayee HK, Havekes B, Corssmit EP et al (2009) Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior. Endocr Relat Cancer 16:291\u2013299","journal-title":"Endocr Relat Cancer"},{"key":"72_CR74","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1677\/ERC-10-0004","volume":"17","author":"MB Lodish","year":"2010","unstructured":"Lodish MB, Adams KT, Huynh TT et al (2010) Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl. Endocr Relat Cancer 17:581\u2013588","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"72_CR75","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1210\/jc.2011-0333","volume":"96","author":"KS King","year":"2011","unstructured":"King KS, Chen CC, Alexopoulos DK et al (2011) Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18-fluorodopamine, 18-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J Clin Endocrinol Metab 96(9):2779\u20132785","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"72_CR76","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","volume":"25","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Kozupa A, Chen CC et al (2007) Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 25(16):2262\u20132269","journal-title":"J Clin Oncol"},{"issue":"1","key":"72_CR77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/ERC-11-0243","volume":"19","author":"JS Fonte","year":"2012","unstructured":"Fonte JS, Robles JF, Chen CC et al (2012) False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease. Endocr Relat Cancer 19(1):83\u201393","journal-title":"Endocr Relat Cancer"},{"issue":"26","key":"72_CR78","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM197706302962609","volume":"296","author":"JA Carney","year":"1977","unstructured":"Carney JA, Sheps SG, Go VL et al (1977) The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med 296(26):1517\u20131518","journal-title":"N Engl J Med"},{"issue":"6","key":"72_CR79","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4065\/74.6.543","volume":"74","author":"JA Carney","year":"1999","unstructured":"Carney JA (1999) Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc 74(6):543\u2013552","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"72_CR80","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1210\/jc.2007-0797","volume":"92","author":"L Matyakhina","year":"2007","unstructured":"Matyakhina L, Bei TA, McWhinney SR et al (2007) Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J Clin Endocrinol Metab 92(8):2938\u20132943","journal-title":"J Clin Endocrinol Metab"},{"key":"72_CR81","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","volume":"10","author":"FH Nederveen van","year":"2009","unstructured":"van Nederveen FH, Gaal J, Favier J et al (2009) An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 10:764\u2013771","journal-title":"Lancet Oncol"},{"issue":"4","key":"72_CR82","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1530\/ERC-14-0254","volume":"21","author":"F Haller","year":"2014","unstructured":"Haller F, Moskalev EA, Faucz FR et al (2014) Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad. Endocr Relat Cancer 21(4):567\u2013577","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"72_CR83","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ejhg.2015.142","volume":"24","author":"SA Boikos","year":"2016","unstructured":"Boikos SA, Xekouki P, Fumagalli E et al (2016) Carney triad can be (rarely) associated with germline succinate dehydrogenase defects. Eur J Hum Genet 24(4):569\u2013573","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"72_CR84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.10235","volume":"108","author":"JA Carney","year":"2002","unstructured":"Carney JA, Stratakis CA (2002) Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet 108(2):132\u2013139","journal-title":"Am J Med Genet"},{"issue":"10","key":"72_CR85","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMc071191","volume":"357","author":"SR McWhinney","year":"2007","unstructured":"McWhinney SR, Pasini B, Stratakis CA, International Carney Triad and Carney-Stratakis Syndrome Consortium (2007) Familial gastrointestinal stromal tumors and germ-line mutations. N Engl J Med 357(10):1054\u20131056","journal-title":"N Engl J Med"},{"issue":"1","key":"72_CR86","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.1009199108","volume":"108","author":"KA Janeway","year":"2011","unstructured":"Janeway KA, Kim SY, Lodish M et al (2011) Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci U S A 108(1):314\u2013318","journal-title":"Proc Natl Acad Sci U S A"},{"key":"72_CR87","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577\u2013580","journal-title":"Science"},{"key":"72_CR88","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/modpathol.2013.47","volume":"26","author":"S Huss","year":"2013","unstructured":"Huss S, Kunstlinger H, Wardelmann E et al (2013) A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del). Mod Pathol 26:1004\u20131012","journal-title":"Mod Pathol"},{"key":"72_CR89","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/PAS.0000000000000418","volume":"39","author":"S Rossi","year":"2015","unstructured":"Rossi S, Gasparotto D, Miceli R et al (2015) KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population based study. Am J Surg Pathol 39:922\u2013930","journal-title":"Am J Surg Pathol"},{"key":"72_CR90","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/gcc.20589","volume":"47","author":"NP Agaram","year":"2008","unstructured":"Agaram NP, Wong GC, Guo T et al (2008) Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes Chromosom Cancer 47:853\u2013859","journal-title":"Genes Chromosom Cancer"},{"key":"72_CR91","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/path.4677","volume":"238","author":"M Brenca","year":"2016","unstructured":"Brenca M, Rossi S, Polano M et al (2016) Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST. J Pathol 238:543\u2013549","journal-title":"J Pathol"},{"key":"72_CR92","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1309\/AJCPPCKGA2QGBJ1R","volume":"133","author":"I Hostein","year":"2010","unstructured":"Hostein I, Faur N, Primois C et al (2010) BRAF mutation status in gastrointestinal stromal tumors. Am J Clin Pathol 133:141\u2013148","journal-title":"Am J Clin Pathol"},{"key":"72_CR93","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/PAS.0b013e3182613c86","volume":"37","author":"J Lasota","year":"2013","unstructured":"Lasota J, Wang Z, Kim SY et al (2013) Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications. Am J Surg Pathol 37:114\u2013119","journal-title":"Am J Surg Pathol"},{"key":"72_CR94","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.pas.0000176433.81079.bd","volume":"30","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Fetsch JF, Sobin LH et al (2006) Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 30:90\u201396","journal-title":"Am J Surg Pathol"},{"key":"72_CR95","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1158\/1078-0432.CCR-11-2230","volume":"18","author":"C Miranda","year":"2012","unstructured":"Miranda C, Nucifora M, Molinari F et al (2012) KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors. Clin Cancer Res 18:1769\u20131776","journal-title":"Clin Cancer Res"},{"key":"72_CR96","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.path.2015.05.006","volume":"8","author":"DT Patil","year":"2015","unstructured":"Patil DT, Rubin BP (2015) Genetics of gastrointestinal stromal tumors: a heterogeneous family of tumors? Surg Pathol Clin 8:515\u2013524","journal-title":"Surg Pathol Clin"},{"issue":"5","key":"72_CR97","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1200\/JCO.2016.68.6733","volume":"35","author":"CB Weldon","year":"2017","unstructured":"Weldon CB, Madenci AL, Boikos SA et al (2017) Surgical management of wild-type gastrointestinal stromal tumors: a report from the National Institutes of Health pediatric and wildtype GIST clinic. J Clin Oncol 35(5):523\u2013528","journal-title":"J Clin Oncol"},{"issue":"2","key":"72_CR98","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ejhg.2013.128","volume":"22","author":"Y Jamilloux","year":"2014","unstructured":"Jamilloux Y, Favier J, Pertuit M et al (2014) A MEN1 syndrome with a paraganglioma. Eur J Hum Genet 22(2):283\u2013285","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"72_CR99","first-page":"495","volume":"100","author":"F Farhi","year":"1976","unstructured":"Farhi F, Dikman SH, Lawson W et al (1976) Paragangliomatosis associated with multiple endocrine adenomas. Arch Pathol Lab Med 100(9):495\u2013498","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"72_CR100","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1210\/jc.2011-1179","volume":"97","author":"P Xekouki","year":"2012","unstructured":"Xekouki P, Pacak K, Almeida M et al (2012) Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? J Clin Endocrinol Metab 97(3):E357\u2013E366","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"72_CR101","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","volume":"100","author":"J D\u00e9nes","year":"2015","unstructured":"D\u00e9nes J, Swords F, Rattenberry E et al (2015) Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort. J Clin Endocrinol Metab 100(3):E531\u2013E541","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"72_CR102","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1210\/jc.2014-4297","volume":"100","author":"P Xekouki","year":"2015","unstructured":"Xekouki P, Szarek E, Bullova P et al (2015) Pituitary adenoma with paraganglioma\/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice. J Clin Endocrinol Metab 100(5):E710\u2013E719","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"72_CR103","doi-asserted-by":"crossref","first-page":"E1386","DOI":"10.1210\/jc.2015-2689","volume":"100","author":"ND Niemeijer","year":"2015","unstructured":"Niemeijer ND, Papathomas TG, Korpershoek E et al (2015) Succinate dehydrogenase (SDH)-deficient pancreatic neuroendocrine tumor expands the SDH-related tumor spectrum. J Clin Endocrinol Metab 100(10):E1386\u2013E1393","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"72_CR104","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","volume":"38","author":"AJ Gill","year":"2014","unstructured":"Gill AJ, Hes O, Papathomas T et al (2014) Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol 38(12):1588\u20131602","journal-title":"Am J Surg Pathol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s42000-018-0072-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0072-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0072-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:14:11Z","timestamp":1574122451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s42000-018-0072-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1007\/s42000-018-0072-y","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"26 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Stratakis holds patents on the PRKAR1A and other genes of the cyclic AMP pathway and their genetics and applications. Dr. Stratakis\u2019 lab has received research funding from Pfizer Inc. for the study of gigantism and\/or acromegaly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}